As of 2026-03-13, the Relative Valuation of Bioventus Inc (BVS) is 4.90 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.60 USD, the upside of Bioventus Inc based on Relative Valuation is -43.0%.
The range of the Relative Valuation is 3.27 - 6.60 USD.
| Range | Selected | |
| Trailing P/E multiples | 55.0x - 69.8x | 64.5x |
| Forward P/E multiples | 34.6x - 49.6x | 39.3x |
| Fair Price | 3.27 - 6.60 | 4.90 |
| Upside | -62.0% - -23.3% | -43.0% |
| Date | P/E |
| 2026-03-12 | 91.00 |
| 2026-03-11 | 94.18 |
| 2026-03-10 | 93.75 |
| 2026-03-09 | 91.11 |
| 2026-03-06 | 88.99 |
| 2026-03-05 | 96.29 |
| 2026-03-04 | 89.63 |
| 2026-03-03 | 92.48 |
| 2026-03-02 | 92.80 |
| 2026-02-27 | 92.91 |
| 2026-02-26 | 93.75 |
| 2026-02-25 | 92.59 |
| 2026-02-24 | 92.27 |
| 2026-02-23 | 91.64 |
| 2026-02-20 | 90.79 |
| 2026-02-19 | 90.79 |
| 2026-02-18 | 89.84 |
| 2026-02-17 | 88.68 |
| 2026-02-13 | 87.51 |
| 2026-02-12 | 85.71 |
| 2026-02-11 | 85.50 |
| 2026-02-10 | 85.39 |
| 2026-02-09 | 90.16 |
| 2026-02-06 | 90.05 |
| 2026-02-05 | 86.88 |
| 2026-02-04 | 85.71 |
| 2026-02-03 | 87.19 |
| 2026-02-02 | 86.88 |
| 2026-01-30 | 83.91 |
| 2026-01-29 | 82.75 |
| 2026-01-28 | 82.11 |
| 2026-01-27 | 83.81 |
| 2026-01-26 | 83.49 |
| 2026-01-23 | 84.87 |
| 2026-01-22 | 86.24 |
| 2026-01-21 | 84.65 |
| 2026-01-20 | 81.59 |
| 2026-01-16 | 83.91 |
| 2026-01-15 | 84.55 |
| 2026-01-14 | 81.90 |
| 2026-01-13 | 81.48 |
| 2026-01-12 | 82.01 |
| 2026-01-09 | 84.97 |
| 2026-01-08 | 84.65 |
| 2026-01-07 | 80.53 |
| 2026-01-06 | 80.95 |
| 2026-01-05 | 80.10 |
| 2026-01-02 | 76.29 |
| 2025-12-31 | 78.73 |
| 2025-12-30 | 78.83 |